Health Catalyst HCAT Ratios & Valuation
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 49.9%+1.1pp | 48.7%+2.2pp | 46.5%+1.2pp | 45.3%+0.1pp | 45.2%-0.7pp | |
| Operating margin | -81.7%-30.0pp | -51.7%-22.5pp | -29.2%-1.2pp | -28%-6.4pp | -21.6%+1.2pp | |
| Net margin | -87.7%-30.5pp | -57.2%-23.2pp | -34.1%-2.4pp | -31.7%-8.3pp | -23.3%-0.7pp | |
| Returns | ||||||
| Return on equity | -103%-44.8pp | -58.3%-26.9pp | -31.3%-2.9pp | -28.4%-8.6pp | -19.8%-0.8pp | |
| Return on invested capital | -72.1%-35.7pp | -36.4%-14.8pp | -21.6%+5.9pp | -27.4%-11.5pp | -16%-2.4pp | |
| Efficiency | ||||||
| Asset turnover | 0.5×0.0× | 0.5×0.0× | 0.5×0.0× | 0.5×+0.1× | 0.4×0.0× | |
| Liquidity | ||||||
| Current ratio | 1.7×-0.2× | 1.9×0.0× | 1.9×+0.1× | 1.8×+0.6× | 1.2×-0.2× | |
| Leverage | ||||||
| Debt-to-equity | 1.2×+0.5× | 0.7×+0.2× | 0.5×0.0× | 0.5×-0.6× | 1.1×0.0× | |
| Per Share | ||||||
| Book value per share | $1.90-45.9% | $3.52-25.4% | $4.72-5.5% | $4.99-9.2% | $5.50-9.4% | |
| Valuation | ||||||
| Market capitalization | $147.05M-43.6% | $169.05M-15.7% | $200.56M-23.1% | $260.66M-18.0% | $318.05M-26.1% | |
| Price / sales | 0.5×-0.3× | 0.5×-0.1× | 0.6×-0.2× | 0.8×-0.2× | 1×-0.4× | |
| Price / book | 1.1×+0.3× | 0.7×+0.1× | 0.6×-0.1× | 0.8×-0.1× | 0.8×-0.3× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Health Catalyst's profit margins?
- Health Catalyst (HCAT) runs a 49.9% gross margin and a -81.7% operating margin, with a -87.7% net margin.
- Where do Health Catalyst's ratios come from?
- Every ratio is computed from Health Catalyst's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
